Page URL: https://www.bionews.org.uk/page_159106

Rejuvenation of stem cell epigenome offers osteoporosis hope

20 September 2021
Appeared in BioNews 1113

The mechanism responsible for changes in bone function during ageing has been found to be hidden within the epigenome, opening possibilities for bone rejuvenation and treatment.

As we age, our bones become thinner, bringing a greater risk of bone fractures and diseases such as osteoporosis. However, a recent study, published in Nature Ageing, has proposed that the reason for this is due to changes in the epigenome, specifically in mesenchymal stem cells, which are found in bone marrow and make many different types of cells such as cartilage, bone and fat.

Andromachi Pouikli, first author of the study, explained that 'we wanted to know why these stem cells produce less material for the development and maintenance of bones as we age, causing more and more fat to accumulate in the bone marrow.'

To identify how the stem cell epigenome had changed over time, researchers from the Max Planck Institute for Biology of Ageing in Cologne, Germany and the University of Cologne compared the epigenome in bones from young and old mice.

The researchers found that key epigenetic differences were due to a protein family called histones, and the chemical modifications associated with them. Histones are able to modulate how accessible the DNA is, and thereby can regulate whether certain genes are able to become active or silent. Over time, a histone modification called acetylation was reduced in the stem cells as its mitochondrial carriers degraded, lowering the activity of bone-forming genes.

To determine whether the epigenetic ageing process was reversible, mouse mesenchymal stem cells were treated with a solution containing the nutrient sodium acetate. The stem cells were able to use the sodium acetate for histone acetylation, which resulted in the DNA becoming more accessible. This led to a rejuvenation of the expression of genes involved in bone marrow integrity and the production of bone cells.

The researchers went on to study human mesenchymal stem cells from patients with osteoporosis and discovered that the human cells showed the same epigenetic changes that were seen in the mice, leading to the belief that stem cell therapies could be developed to treat osteoporosis.

However, corresponding author Dr Peter Tessarz warned: 'Sodium acetate is also available as a food additive, however, it is not advisable to use it in this form against osteoporosis, as our observed effect is very specific to certain cells... We still need to investigate in more detail the effects on the whole organism in order to exclude possible risks and side effects.'

SOURCES & REFERENCES
Chromatin remodeling due to degradation of citrate carrier impairs osteogenesis of aged mesenchymal stem cells
Nature Ageing |  13 September 2021
Epigenetic changes in ageing stem cells rejuvenated by acetate
Genetic Engineering and Biotechnology News |  15 September 2021
Fountain of youth for ageing stem cells in bone marrow
Max-Planck-Gesellschaft |  13 September 2021
Stem cells could be key to osteoporosis treatment
Cosmos |  15 September 2021
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
4 October 2021 - by Hannah Flynn 
Scientists have described a method to create cartilage from human embryonic stem cells...
27 September 2021 - by Joseph Hawkins 
Artificial mitochondria capable of releasing energy, which can be used to repair damaged cells, have been created, claim a team of researchers...
5 July 2021 - by Semyon Bodian 
Germline cells seem to reset their biological clocks around the time of embryo implantation, not when generating gametes, as previously thought...
30 March 2020 - by Dr Molly Godfrey 
Researchers have returned stem cells from older donors to a more youthful biological state...
27 February 2017 - by Annabel Slater 
'Introducing Epigenetics: A graphic guide' is a mini-textbook pitched as a non-fiction comic book. Despite the colourful cover and perky graphics inside, this book does not make for light reading...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.